Top Pharmaceutical Companies in San Antonio, TX (12)
InGenesis, Inc. is a healthcare services firm specializing in workforce solutions and medical management services. Founded in 1998, its mission is to improve lives by connecting quality professionals—including nurses, physicians, and allied health practitioners—with purposeful work across healthcare, life sciences, higher education, and pharmaceutical industries. The company is recognized as a leading diversity supplier of healthcare workforce solutions in America.
InGenesis, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Market presence is characterized by recognition among the largest healthcare staffing firms and leadership accolades, suggesting a durable competitive standing in specialized healthcare workforce solutions.
Strategic Partnerships: Expansion through notable acquisitions such as Kelly Healthcare Resources and large-scale federal contracting vehicles reflects effective external alliances that extend service breadth and scale.
Strong Brand Reputation: Certifications like The Joint Commission Gold Seal and ISO 22956:2021, along with alignment to Baldrige principles, point to a reputation grounded in quality and operational rigor.
Deeply rooted in community oncology centers globally, the START Center for Cancer Research ('START') provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,500 early phase clinical trials, including for 50 therapies that have...
U.S. Dermatology Partners is one of the largest physician-owned dermatology practices in the United States, providing premier medical, surgical, and cosmetic skin care to over two million patients annually. With more than 130 locations across nine states, the organization focuses on patient-first care, combining the personalized experience of private practice with a coordinated network of specialized physicians and national thought...
Cantex Continuing Care Network provides a comprehensive continuum of care, including skilled nursing, rehabilitation, home health, hospice, and pharmacy services, focused on promoting recovery and enhancing patient quality of life.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
About Worldwide Clinical Trials Worldwide Clinical Trials is a global, midsize contract research organization (CRO) that provides top-performing bioanalytical and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986 by physicians committed to advancing medical science, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world...
Texas Biomedical Research Institute is a premiere, independent research institute dedicated to advancing human health worldwide by pioneering and sharing scientific breakthroughs in the nature, causes, prevention, and eradication of infectious diseases and related co-morbidities.
Headquartered in Louisville, Kentucky, PharMerica is one of the largest institutional pharmacy companies in the U.S. With more than 180 long-term care pharmacies in almost every state, we offer a national scope with a local approach, as well as unmatched clinical quality and customer care. With approximately 6,000 dedicated employees, PharMerica is proud to be home to some of the industry’s...
PharMerica's Top Stability & Growth Strengths
Strong Market Position & Advantage: PharMerica is widely recognized as a national leader in institutional and long‑term care pharmacy, with a broad footprint and specialized offerings across multiple care settings. Its integration within BrightSpring’s pharmacy platform and extensive distribution network reinforce a durable competitive position.
Market Expansion: The company continues to scale its operational footprint through facility upgrades, added locations, and active hiring in operations and finance. Acquisitions and multi‑state growth initiatives indicate sustained reach across key markets.
Strategic Partnerships: Collaborations with medication‑management and health‑technology providers, including initiatives to improve adherence and rural access, expand service capabilities. Technology integrations with EHR and e‑prescribing systems support clients navigating complex compliance demands.
Neurolink is an early-stage company developing a novel therapy for the treatment of epilepsy.
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
Amerita, Inc. is a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost-effective delivery settings, a growing bio-pharmaceutical pipeline of
